Presence of a High Amount of Stroma and Downregulation of SMAD4 Predict for Worse Survival for Stage I–II Colon Cancer Patients

Background: For stage I–II colon cancer a significant number (5–25%) of patients has recurrent disease within 5 years. There is need to identify these high-risk patients as they might benefit from additional treatment.

Saved in:
Bibliographic Details
Main Authors: Wilma E. Mesker, Gerrit-Jan Liefers, Jan M. C. Junggeburt, Gabi W. van Pelt, Paola Alberici, Peter J. K. Kuppen, Noel F. Miranda, Karin A. M. van Leeuwen, Hans Morreau, Karoly Szuhai, Rob A. E. M. Tollenaar, Hans J. Tanke
Format: Article
Language:English
Published: Wiley 2009-01-01
Series:Cellular Oncology
Online Access:http://dx.doi.org/10.3233/CLO-2009-0478
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832549477814108160
author Wilma E. Mesker
Gerrit-Jan Liefers
Jan M. C. Junggeburt
Gabi W. van Pelt
Paola Alberici
Peter J. K. Kuppen
Noel F. Miranda
Karin A. M. van Leeuwen
Hans Morreau
Karoly Szuhai
Rob A. E. M. Tollenaar
Hans J. Tanke
author_facet Wilma E. Mesker
Gerrit-Jan Liefers
Jan M. C. Junggeburt
Gabi W. van Pelt
Paola Alberici
Peter J. K. Kuppen
Noel F. Miranda
Karin A. M. van Leeuwen
Hans Morreau
Karoly Szuhai
Rob A. E. M. Tollenaar
Hans J. Tanke
author_sort Wilma E. Mesker
collection DOAJ
description Background: For stage I–II colon cancer a significant number (5–25%) of patients has recurrent disease within 5 years. There is need to identify these high-risk patients as they might benefit from additional treatment.
format Article
id doaj-art-e069bfb964f541919fccf088d96efb12
institution Kabale University
issn 1570-5870
1875-8606
language English
publishDate 2009-01-01
publisher Wiley
record_format Article
series Cellular Oncology
spelling doaj-art-e069bfb964f541919fccf088d96efb122025-02-03T06:11:14ZengWileyCellular Oncology1570-58701875-86062009-01-0131316917810.3233/CLO-2009-0478Presence of a High Amount of Stroma and Downregulation of SMAD4 Predict for Worse Survival for Stage I–II Colon Cancer PatientsWilma E. Mesker0Gerrit-Jan Liefers1Jan M. C. Junggeburt2Gabi W. van Pelt3Paola Alberici4Peter J. K. Kuppen5Noel F. Miranda6Karin A. M. van Leeuwen7Hans Morreau8Karoly Szuhai9Rob A. E. M. Tollenaar10Hans J. Tanke11Department of Molecular Cell Biology, Leiden University Medical Center, Leiden, The NetherlandsDepartment of Surgery, Leiden University Medical Center, Leiden, The NetherlandsDepartment of Surgery, Leiden University Medical Center, Leiden, The NetherlandsDepartment of Surgery, Leiden University Medical Center, Leiden, The NetherlandsDepartment of Molecular Cell Biology, Leiden University Medical Center, Leiden, The NetherlandsDepartment of Surgery, Leiden University Medical Center, Leiden, The NetherlandsDepartment of Pathology, Leiden University Medical Center, Leiden, The NetherlandsDepartment of Pathology, Rijnland Hospital, Leiderdorp, The NetherlandsDepartment of Pathology, Leiden University Medical Center, Leiden, The NetherlandsDepartment of Molecular Cell Biology, Leiden University Medical Center, Leiden, The NetherlandsDepartment of Surgery, Leiden University Medical Center, Leiden, The NetherlandsDepartment of Molecular Cell Biology, Leiden University Medical Center, Leiden, The NetherlandsBackground: For stage I–II colon cancer a significant number (5–25%) of patients has recurrent disease within 5 years. There is need to identify these high-risk patients as they might benefit from additional treatment.http://dx.doi.org/10.3233/CLO-2009-0478
spellingShingle Wilma E. Mesker
Gerrit-Jan Liefers
Jan M. C. Junggeburt
Gabi W. van Pelt
Paola Alberici
Peter J. K. Kuppen
Noel F. Miranda
Karin A. M. van Leeuwen
Hans Morreau
Karoly Szuhai
Rob A. E. M. Tollenaar
Hans J. Tanke
Presence of a High Amount of Stroma and Downregulation of SMAD4 Predict for Worse Survival for Stage I–II Colon Cancer Patients
Cellular Oncology
title Presence of a High Amount of Stroma and Downregulation of SMAD4 Predict for Worse Survival for Stage I–II Colon Cancer Patients
title_full Presence of a High Amount of Stroma and Downregulation of SMAD4 Predict for Worse Survival for Stage I–II Colon Cancer Patients
title_fullStr Presence of a High Amount of Stroma and Downregulation of SMAD4 Predict for Worse Survival for Stage I–II Colon Cancer Patients
title_full_unstemmed Presence of a High Amount of Stroma and Downregulation of SMAD4 Predict for Worse Survival for Stage I–II Colon Cancer Patients
title_short Presence of a High Amount of Stroma and Downregulation of SMAD4 Predict for Worse Survival for Stage I–II Colon Cancer Patients
title_sort presence of a high amount of stroma and downregulation of smad4 predict for worse survival for stage i ii colon cancer patients
url http://dx.doi.org/10.3233/CLO-2009-0478
work_keys_str_mv AT wilmaemesker presenceofahighamountofstromaanddownregulationofsmad4predictforworsesurvivalforstageiiicoloncancerpatients
AT gerritjanliefers presenceofahighamountofstromaanddownregulationofsmad4predictforworsesurvivalforstageiiicoloncancerpatients
AT janmcjunggeburt presenceofahighamountofstromaanddownregulationofsmad4predictforworsesurvivalforstageiiicoloncancerpatients
AT gabiwvanpelt presenceofahighamountofstromaanddownregulationofsmad4predictforworsesurvivalforstageiiicoloncancerpatients
AT paolaalberici presenceofahighamountofstromaanddownregulationofsmad4predictforworsesurvivalforstageiiicoloncancerpatients
AT peterjkkuppen presenceofahighamountofstromaanddownregulationofsmad4predictforworsesurvivalforstageiiicoloncancerpatients
AT noelfmiranda presenceofahighamountofstromaanddownregulationofsmad4predictforworsesurvivalforstageiiicoloncancerpatients
AT karinamvanleeuwen presenceofahighamountofstromaanddownregulationofsmad4predictforworsesurvivalforstageiiicoloncancerpatients
AT hansmorreau presenceofahighamountofstromaanddownregulationofsmad4predictforworsesurvivalforstageiiicoloncancerpatients
AT karolyszuhai presenceofahighamountofstromaanddownregulationofsmad4predictforworsesurvivalforstageiiicoloncancerpatients
AT robaemtollenaar presenceofahighamountofstromaanddownregulationofsmad4predictforworsesurvivalforstageiiicoloncancerpatients
AT hansjtanke presenceofahighamountofstromaanddownregulationofsmad4predictforworsesurvivalforstageiiicoloncancerpatients